A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

Inclusion Criteria: * In good health with no underlying medical condition that, according to the Investigator, would place a subject at risk * Having given written informed consent Exclusion Criteria: * Evidence of any malignancy * Use of any tobacco product within 7 years of study entry * Pregnant or lactating women * History of drug abuse * Clinically significant abnormal screening ECG * Abnormal vital signs * Use of systemic steroidal therapy), immunotherapy, cytotoxic, chemotherapy or any investigational drug or device within 30 days of study entry. Topical steroids are allowed * Women, 40 years of age and above, who have not had a mammography within one year of study entry * Men and women, 50 years of age and above, who have not had a sigmoidoscopy within 5 years and colonoscopy within 10 years of study entry